← Back to patent-cliff list
Oxycodone
Tier C — Watch / tradeOxycodone
Collegium Pharm
Originator
2004
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Opioid receptors
Brand：OxyFast, Xtampza Er, ORADUR, OxylR, OxyIR, Remoxy, OxyNorm
Indications (approved)：Pain
Regional status
US
Approved
2016-04-26
EU
Phase I
2025-06-12
China
Approved
2004-01-21
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Oxycodone?
Approved indications include: Pain.
When does the Oxycodone patent expire?
No public expiry year is available for Oxycodone yet; this page updates once verified.
How do I get a quote for Oxycodone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27